Prevalence of Bartonella spp. seropositivity in human immunodeficiency virus-infected and non infected intravenous drug abusers;Prevalencia de seropositividad para Bartonella spp. en pacientes adictos a drogas por vía parenteral infectados y no infectados por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 119, Issue 15, 2002, Pages 565-567

  Ramos, Antonio J ^a   Vargas, Julio ^a   Fernández Rivera, Javier ^a   Macías, Juan ^a   Mira, José A ^a   Pineda, Juan A ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Bacillary angiomatosis; Bartonella AIDS; Cat scracht disease; HIV

Indexed keywords

BACTERIUM ANTIBODY; CD4 ANTIGEN; IMMUNOGLOBULIN G;

ADULT; ANTIBODY TITER; ARTICLE; BARTONELLA; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; RICKETTSIOSIS; SEROEPIDEMIOLOGY; VIRUS CARRIER;

EID: 0037010501     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)73500-8     Document Type: Article

References (10)

1. Anderson BE, Neuman MA. Bartonella spp. as emerging human pathogens. Clin Microbiol Rev 1997;10:203-19.
2. Jensen WA, Fall MZ, Rooney J, Kordick D, Breitschwerdt EB. Rapid identification and differentiation of Bartonella species using a single-step PCR assay. J Clin Microbiol 2000;38:1717-22.
3. Bosch X, Segura-Corrales J, Solé M, Martínez-Oronzo F. Diagnóstico serológico de la enfermedad por arañazo de gato. Med Clin (Barc) 1998; 111:478.
4. Bergmans AMC, Peeters MF, Schellekens JFP, Vos MC, Sabbe LJM, Ossewarde JM, et al. Pitfalls and fallacies of cat scracht disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay. J Clin Microbiol 1997;35:1931-7.
5. Gallardo JA, Pineda JA, Macías J, Torronteras R, Lissen E. Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1. Trans R Soc Med Hyg 1996;90:383.
6. Raoult D. Infeccions humanas por Bartonella. En: Picazo JJ, Bouza E, editores. Infección 1999. Madrid: Servisistem 2000 S.L., 1999; p. 340-56.
7. Comer JA, Flynn C, Regnery RL, Vlahov D, Childs JE. Antibodies to Bartonella spp. in inner-city intravenous drug users in Baltimore, MD, Arch Intern Med 1996;156:2491-5.
8. Pineda JA, Gallardo JA, Macías J, Delgado J, Regordán C, Morillas F, et al. Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain. J Clin Microbiol 1998;36:2419-22.
9. Pineda JA, Macías J, Morillas F, Fernández-Ochoa J, Cara J, De la Rosa R, et al. Evidence of an increased risk for Leishmania infantum infection among HIV-seronegative IDU from Southern Spain. Eur J Clin Microbiol Infect Dis 2001; 20:1-4.
10. Blanco JR, Oteo JA, Martínez V, Ramalle E, García A, Ibarra V, et al. Seroepidemiología de la infección por Bartonella henselae en pacientes infectados por el VIH. Enf Infec Microbiol Clin 1999;17:434-8.